Alto Neuroscience Inc.

ANRONYSEUSD
30.93 USD
0.68 (2.23%)🟢LIVE (AS OF 12:07 PM EDT)
🟢Market: OPEN

Alto Neuroscience Inc. (ANRO) trades at $30.93 per share. Our models show a "Sell" technical signal alongside a "Neutral" fundamental rating. Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation metrics place ANRO at a fair price relative to peers.

Technical & fundamental data as of Sep 15, 2026.

Open?$30.50
High?$31.17
Low?$30.08
Prev. Close?$30.25
Volume?125.1K
Avg. Volume?472.7K
VWAP?$30.80
Rel. Volume?0.26x
Bid / Ask
Bid?$30.98 × 100
Ask?$31.06 × 100
Spread?$0.08
Midpoint?$31.02
Valuation & Ratios
Market Cap?1.2B
Shares Out?39.2M
Float?26.1M
Float %?74.3%
P/E Ratio?N/A
P/B Ratio?5.41
EPS?-$2.15
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individual's neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-207, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers.
Employees
68
Market Cap
1.2B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2024-02-02
Address
650 CASTRO STREET, SUITE 450
MOUNTAIN VIEW, CA 94041
Phone: 773-255-5012
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Neutral(0/3)
Medium-Term (Wave)? Bearish(-2/3)
Short-Term (Ripple)? Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
65
Short Sent.?
29
Piotroski F-Score?0/9Weak
Altman Z-Score?18.99Safe
Confidence?48%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?14.71%High
Short Interest?3.8M
Days to Cover?8.1
Free Float26.1M
Avg Daily Volume475.8K
Settlement Date2026-08-31
Financial Health
Current Ratio?14.85Strong
Quick Ratio?14.85Strong
Cash Ratio?14.64Strong
Debt/Equity?0.09Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A
P/B?
Peers
100
S&P
34
5.41FAIR
P/S?
N/A
P/FCF?
N/A
EV/EBITDA?
S&P
97
-11.0CHEAP
EV/Sales?
N/A
Returns & Efficiency
ROE?
S&P
3
-38.4%WEAK
ROA?
S&P
3
-33.2%WEAK
Cash Flow & Enterprise
FCF?$-68841000
Enterprise Value?$962.0M
Fundamentals ratios updated end of day